TechBio France 2024

Future4care is a European ecosystem of multidisciplinary actors dedicated to digital health. Founded in 2021 as a Joint Venture by Orange, Capgemini, Sanofi, and Generali, Future4care brings together major players in E-health (corporations, scientific experts, healthcare professionals, startups, etc.) on a 6500m2 campus in Paris to foster dialogue and create synergies and opportunities that accelerate digital transformation in our healthcare systems. Since its launch, Future4care has been joined by diverse industrial and institutional partners. It recently opened a hub in Berlin, Germany, to drive progress in Germany and expand the European ecosystem.

Future4care

Join TechBio France 2024 to shape the future of France's TechBio ecosystem, fostering innovation and collaboration in biotech and technology

WhiteLab Genomics has launched an initiative to develop the French TechBio sector in collaboration with four key stakeholders from the national innovation ecosystem : <ul><li>France Biotech (FB): an independent association bringing together HealthTech innovation entrepreneurs in France since 1997. In late 2023, FB had launched a dedicated task force dedicated to the use of AI solutions in Drug discovery, with the support of with ADLIN Science, Orakl Oncology and WhiteLab.</li></ul> <ul><li>Future4care: born of the alliance between Orange, Sanofi, Generali and Capgemini, brings together corporates and startups in a unique ecosystem to develop cutting-edge digital solutions.</li></ul> <ul><li>AIforhealth is the leading European ecosystem bridging together the public-private stakeholders from the AI &amp; health sectors. The 7th edition of their annual Summit will take place on Nov. 21st at Station F with 2,000 expected attendees, and</li></ul> <ul><li>France Deeptech: the community that brings together and federates the various stakeholders of the Deeptech sector.</li></ul> As a first concrete action, WhiteLab and these four partners have agreed to join forces to organize an event dedicated to TechBio at Future4care, 8 Rue Jean Antoine de Baïf, 75013 Paris on November 20: Open conference – November 20 morning: During this conference, we will address key challenges associated with the Techbio ecosystem through multiple round tables, keynotes and a networking lunch: <ul><li>Introduction to TechBio - Myths vs Reality</li><li>The high-stakes challenge of TechBio</li><li>Funding the TechBio revolution: strategies and opportunities</li><li>Revolutionizing AI Drug Discovery "Made in France" - Competing on Global Stage</li><li>Presentation of the study on French TechBio startups sponsored by France Biotech</li></ul> Detailed Program to be disclosed This will be an unparalleled gathering of over 250 industry leaders, entrepreneurs, investors and experts. It would be an honor to have you with us.

Calendrier

Reception and Registration

David Del Bourgo (CEO and co-founder of WhiteLab Genomics), Agnès De Leersnyder (CEO of Future4care), Damien Gromier (CEO and founder of AI for Health), Michel De Lempdes (President of France Deeptech), Frederic Girard (President of France Biotech), and Matthieu Landon (conseiller économique, chef de pôle at Présidence de la République) with Julie Huguet (Director of Mission French Tech) will lead the opening and general introduction of TechBio France 2024.

Opening, General introduction

Round Table #1 at TechBio France 2024, titled "TechBio – Myths vs Reality," will feature an insightful discussion with Thomas Clozel (CEO and co-founder of Owkin), Marion Pierfitte (COO of Qubit), Julia Gimbernat Mayol (Head of Product at InstaDeep), Magali Richard (Co-founder & Interim COO of One Biosciences), and Kwame Amaning (Digital Innovation/External Ecosystem at Sanofi).

Round Table #1:  TechBio - Myths vs Reality

Keynote #1 at TechBio France 2024 will focus on exploring France's TechBio landscape, delivered by Antonio Borderia, Executive Vice President of Business Development at Adlin Biosciences.

Key Note #1:Exploring France's TechBio Landscape

Coffee Break

Round Table #2 at TechBio France 2024, titled "Funding the TechBio Revolution: Strategies and Opportunities," will bring together key figures including Julie Lellouche (Bpifrance), Fabien Collangettes (Omnes Capital), Estelle Botbol (Speed Invest), Vincent Lepreux (Debiopharm Innovation Fund), and Matthieu Losguardi (Business Development and Think Tank Coordinator at France Biotech).

Round Table  #2: Funding the TechBio revolution: strategies and opportunities

Keynote #2 at TechBio France 2024, titled "The High-Stakes Challenge of TechBio Valuation," will be delivered by Mohamed Chaari from EM Lyon.

Key Note #2: The high-stakes challenge of TechBio Valuation

Round Table #3 at TechBio France 2024, titled "Revolutionizing AI Drug Discovery 'Made in France' – Competing on the Global Stage," will feature a panel including Mohamed-Ramzi Temanni (Senior Director, Head of AI for Systems Biology, Data Science and Digital Health at Johnson & Johnson), Amaury Martin (Deputy Director of Technology Transfer, Data, and Translational Programs at Institut Curie), Yann Gaston Mathe (CEO and co-founder of Iktos), and Aline Charpentier (Head of Innovation, Bruntwood SciTech Advisor for Techbio UK at BIA).

TechBio France 2024

More events from Future4care

Discover more events from Future4care, from Science & Tech to other experiences you might love.

TechBio France 2024

More events from Future4care

Discover more events from Future4care, from Science & Tech to other experiences you might love.

You might also like...

Browse more events with different dates, prices, and formats to find your next great experience.